iShares MSCI EAFE Min Vol Factor ETF (EFAV)
73.74
-0.73 (-0.98%)
USD |
Jan 15, 20:00
Price Chart
Key Stats
Customize
Expense Ratio | Discount or Premium to NAV | Total Assets Under Management | 30-Day Average Daily Volume |
---|---|---|---|
0.20% | -0.23% | 10.56B | 800579.9 |
Dividend Yield | Turnover Ratio | 1 Year Fund Level Flows | Max Drawdown (All) |
3.68% | 23.00% | -1.967B | Upgrade |
Basic Info
Investment Strategy | |
The investment seeks the investment results of the MSCI EAFE Minimum Volatility (USD) Index composed of developed market equities that, in the aggregate, have lower volatility characteristics relative to the broader developed equity markets, excluding the U.S. and Canada. The fund generally will invest at least 90% of its assets in the component securities of the index and in investments that have economic characteristics that are substantially identical to the component securities of the index. The index measures the performance of international equity securities that in the aggregate have lower volatility relative to the MSCI EAFE Index. |
General | |
Security Type | Exchange-Traded Fund |
Equity Style | Large Cap/Blend |
Fixed Income Style | -- |
Broad Asset Class | International Equity |
Broad Category | Equity |
Category Name | Foreign Large Blend |
Category Index | MSCI ACWI Ex USA NR USD |
Prospectus Objective | Foreign Stock |
Fund Owner Firm Name | iShares |
Prospectus Benchmark Index | |
MSCI EAFE Minimum Vol (USD) NR USD | 100.0% |
Broad Asset Class Benchmark Index | |
^MSACXUSNTR | 100.0% |
Manager Tenure | |
Greg Savage | 9.21 yrs |
Jennifer Hsui | 8.09 yrs |
Alan Mason | 4.72 yrs |
Amy Whitelaw | 2.09 yrs |
Rachel Aguirre | 2.09 yrs |
Net Fund Flows Versus Category
1 Month
% Rank:
--
--
Category Low
--
Category High
1 Year
% Rank:
98
-1.967B
-48.29B
Category Low
5.821B
Category High
3 Months
% Rank:
--
--
Category Low
--
Category High
3 Years
% Rank:
--
--
Category Low
--
Category High
6 Months
% Rank:
--
--
Category Low
--
Category High
5 Years
% Rank:
--
--
Category Low
--
Category High
YTD
% Rank:
--
--
Category Low
--
Category High
10 Years
% Rank:
--
--
Category Low
--
Category High
As of December 31, 2020
Performance Versus Category
As of January 15, 2021. Returns for periods of 1 year and above are annualized.
Annual Total Returns Versus Peers
Edit comparables
As of January 15, 2021.
Asset Allocation
Top 10 Holdings
Name | % Weight | Price | % Change |
---|---|---|---|
Novo Nordisk A/S B
|
1.53% | -- | -- |
Chugai Pharmaceutical Co Ltd
|
1.50% | -- | -- |
Roche Holding AG Dividend Right Cert.
|
1.49% | -- | -- |
Swisscom AG
|
1.43% | -- | -- |
Givaudan SA
|
1.43% | -- | -- |
Novartis AG
|
1.38% | -- | -- |
Nestle SA
|
1.35% | -- | -- |
Coloplast A/S B
|
1.34% | -- | -- |
Hermes International SA
|
1.26% | -- | -- |
Unilever PLC
|
1.08% | -- | -- |
News
Headline
Wire
Time (ET)
Basic Info
Investment Strategy | |
The investment seeks the investment results of the MSCI EAFE Minimum Volatility (USD) Index composed of developed market equities that, in the aggregate, have lower volatility characteristics relative to the broader developed equity markets, excluding the U.S. and Canada. The fund generally will invest at least 90% of its assets in the component securities of the index and in investments that have economic characteristics that are substantially identical to the component securities of the index. The index measures the performance of international equity securities that in the aggregate have lower volatility relative to the MSCI EAFE Index. |
General | |
Security Type | Exchange-Traded Fund |
Equity Style | Large Cap/Blend |
Fixed Income Style | -- |
Broad Asset Class | International Equity |
Broad Category | Equity |
Category Name | Foreign Large Blend |
Category Index | MSCI ACWI Ex USA NR USD |
Prospectus Objective | Foreign Stock |
Fund Owner Firm Name | iShares |
Prospectus Benchmark Index | |
MSCI EAFE Minimum Vol (USD) NR USD | 100.0% |
Broad Asset Class Benchmark Index | |
^MSACXUSNTR | 100.0% |
Manager Tenure | |
Greg Savage | 9.21 yrs |
Jennifer Hsui | 8.09 yrs |
Alan Mason | 4.72 yrs |
Amy Whitelaw | 2.09 yrs |
Rachel Aguirre | 2.09 yrs |
Fundamentals
General | |
Distribution Yield | Upgrade |
Dividend Yield TTM (1-15-21) | 3.68% |
30-Day SEC Yield (3-31-20) | Upgrade |
7-Day SEC Yield | -- |
Number of Holdings | Upgrade |
Stock | |
Weighted Average PE Ratio | 22.18 |
Weighted Average Price to Sales Ratio | Upgrade |
Weighted Average Price to Book Ratio | Upgrade |
Weighted Median ROE | Upgrade |
Weighted Median ROA | Upgrade |
Forecasted Dividend Yield | Upgrade |
Forecasted PE Ratio | Upgrade |
Forecasted Price to Sales Ratio | Upgrade |
Forecasted Price to Book Ratio | Upgrade |
As of January 14, 2021
Growth Estimates
Fund Details
Key Dates | |
Inception Date | 10/18/2011 |
Last Annual Report Date | 7/31/2020 |
Last Prospectus Date | 12/1/2020 |
Attributes | |
Enhanced Index Fund | No |
Index Fund |
|
Inverse Fund | No |
Leveraged Fund | No |
Fund of Funds | No |
Currency Hedged Fund | No |
Synthetic Replication Fund | No |
Has Dividend Investment Plan | No |
Socially Responsible Fund | No |
News
Headline
Wire
Time (ET)